Efficacy and safety of certolizumab pegol plus methotrexate in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: the J-RAPID randomized, placebo-controlled trial

Author(s):
Yamamoto, K.; Takeuchi, T.; Yamanaka, H.; Ishiguro, N.; Tanaka, Y.; Eguchi, K.; Watanabe, A.; Origasa, H.; Shoji, T.; Sakamaki, Y.; Heijde, D. van der; Miyasaka, N.; Koike, T.
Published
2014
Publication type
Article / Letter to editor
Certolizumab pegolMethotrexateRandomized controlled trialRheumatoid arthritisTumor necrosis factor-alpha inhibitor
Date issued
2014-09-30
Language
English
Is part of
hdl
1887/103543
doi
10.3109/14397595.2013.864224